What is uFraction8?
Founded in 2017 and headquartered in Falkirk, Scotland, uFraction8 specializes in the development of advanced microfluidics-based filtration systems. The company addresses the inherent inefficiencies in traditional biomanufacturing by utilizing hydrodynamic phenomena to replace conventional, energy-intensive methods such as centrifuges and membrane filtration. This technological shift is essential for industries ranging from biopharmaceuticals to food production, where the demand for scalable, cost-effective, and sustainable downstream processing is at an all-time high. By reducing operational overhead and enhancing throughput, uFraction8 provides a robust solution for companies looking to modernize their production pipelines.
How much funding has uFraction8 raised?
uFraction8 has raised a total of $7.7M across 2 funding rounds:
Other Financing Round
$3.4M
Other Financing Round
$4.3M
Other Financing Round (2022): $3.4M, investors not publicly disclosed
Other Financing Round (2025): $4.3M led by The University of Edinburgh, Thia Ventures, Foresight Group, Alwyn Capital, Old College Capital, and Scottish Enterprise
Key Investors in uFraction8
The University of Edinburgh
A prestigious Scottish research institution renowned for its cross-disciplinary approach to global health and biological sciences.
Thia Ventures
A Singapore-based fund management firm specializing in the intersection of food, biotechnology, and health sectors.
Foresight Group
A leading independent infrastructure and private equity investment manager with a long-standing history of supporting industrial growth.
What's next for uFraction8?
With this latest round of financing, uFraction8 is well-positioned to accelerate its commercialization strategy and expand its footprint within the global biomanufacturing market. The company's trajectory, marked by consistent growth since its inception, suggests a transition toward broader industrial adoption of its filtration systems. Future strategic initiatives will likely focus on scaling manufacturing capabilities and deepening research collaborations to further refine its hydrodynamic solutions. As the industry shifts toward more sustainable and efficient production models, uFraction8's role as a key enabler of bio-based product scalability becomes increasingly vital, setting the stage for potential long-term market leadership.
See full uFraction8 company page
